Citations for
1ZNF423, ZNF521
Direct transcriptional repression of Zfp423 by Zfp521 mediates a bone morphogenic protein-dependent osteoblast versus adipocyte lineage commitment switch.
Addison WN, Fu MM, Yang HX, Lin Z, Nagano K, Gori F, Baron R.
Mol Cell Biol 34(16):3076-85. doi: 10.1128/MCB.00185-14. Epub 2014 Jun 2. 2014
2BMP4, WISP2, ZNF423
WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4.
Hammarstedt A, Hedjazifar S, Jenndahl L, Gogg S, Grünberg J, Gustafson B, Klimcakova E, Stich V, Langin D, Laakso M, Smith U.
Proc Natl Acad Sci U S A 110(7):2563-8. doi: 10.1073/pnas.1211255110. Epub 2013 Jan 28. 2013
3BRCA1, ZNF423
Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention.
Ingle JN, Liu M, Wickerham DL, Schaid DJ, Wang L, Mushiroda T, Kubo M, Costantino JP, Vogel VG, Paik S, Goetz MP, Ames MM, Jenkins GD, Batzler A, Carlson EE, Flockhart DA, Wolmark N, Nakamura Y, Weinshilboum RM.
Cancer Discov 3(7):812-25. doi: 10.1158/2159-8290.CD-13-0038. Epub 2013 Jun 13. 2013
4CEP164, NPHP14, NPHP15, ZNF423
Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling.
Chaki M, Airik R, Ghosh AK, Giles RH, Chen R, Slaats GG, Wang H, Hurd TW, Zhou W, Cluckey A, Gee HY, Ramaswami G, Hong CJ, Hamilton BA, Cervenka I, Ganji RS, Bryja V, Arts HH, van Reeuwijk J, Oud MM, Letteboer SJ, Roepman R, Husson H, Ibraghimov-Beskrovnaya O, Yasunaga T, Walz G, Eley L, Sayer JA, Schermer B, Liebau MC, Benzing T, Le Corre S, Drummond I, Janssen S, Allen SJ, Natarajan S, O'Toole JF, Attanasio M, Saunier S, Antignac C, Koenekoop RK, Ren H, Lopez I, Nayir A, Stoetzel C, Dollfus H, Massoudi R, Gleeson JG, Andreoli SP, Doherty DG, Lindstrad A, Golzio C, Katsanis N, Pape L, Abboud EB, Al-Rajhi AA, Lewis RA, Omran H, Lee EY, Wang S, Sekiguchi JM, Saunders R, Johnson CA, Garner E, Vanselow K, Andersen JS, Shlomai J, Nurnberg G, Nurnberg P, Levy S, Smogorzewska A, Otto EA, Hildebrandt F.
Cell 150(3):533-48. doi: 10.1016/j.cell.2012.06.028. 2012
5ZNF423
Zfp423/OAZ mutation reveals the importance of Olf/EBF transcription activity in olfactory neuronal maturation.
Roby YA, Bushey MA, Cheng LE, Kulaga HM, Lee SJ, Reed RR.
J Neurosci 32(40):13679-88a. doi: 10.1523/JNEUROSCI.6190-11.2012. 2012
6ZNF423
Zfp423 expression identifies committed preadipocytes and localizes to adipose endothelial and perivascular cells.
Gupta RK, Mepani RJ, Kleiner S, Lo JC, Khandekar MJ, Cohen P, Frontini A, Bhowmick DC, Ye L, Cinti S, Spiegelman BM.
Cell Metab 15(2):230-9. doi: 10.1016/j.cmet.2012.01.010. 2012
7NF1, ZNF423
NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome.
Hölzel M, Huang S, Koster J, Ora I, Lakeman A, Caron H, Nijkamp W, Xie J, Callens T, Asgharzadeh S, Seeger RC, Messiaen L, Versteeg R, Bernards R.
Cell 142(2):218-29. 2010
8HES5, ZNF423
ZFP423 coordinates Notch and bone morphogenetic protein signaling, selectively up-regulating Hes5 gene expression.
Masserdotti G, Badaloni A, Green YS, Croci L, Barili V, Bergamini G, Vetter ML, Consalez GG.
J Biol Chem 285(40):30814-24. Epub 2010 Jun 14. 2010
9ZNF423
ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome.
Huang S, Laoukili J, Epping MT, Koster J, Hölzel M, Westerman BA, Nijkamp W, Hata A, Asgharzadeh S, Seeger RC, Versteeg R, Beijersbergen RL, Bernards R.
Cancer Cell 15(4):328-40. 2009
10ZNF423
The transcription factor Zfp423/OAZ is required for cerebellar development and CNS midline patterning.
Cheng LE, Zhang J, Reed RR.
Dev Biol 307(1):43-52. Epub 2007 Apr 12. 2007
11ZNF423
Zfp423 is required for normal cerebellar development.
Warming S, Rachel RA, Jenkins NA, Copeland NG.
Mol Cell Biol 26(18):6913-22. 2006
12ZNF423
Zfp423 controls proliferation and differentiation of neural precursors in cerebellar vermis formation.
Alcaraz WA, Gold DA, Raponi E, Gent PM, Concepcion D, Hamilton BA.
Proc Natl Acad Sci U S A 103(51):19424-9. Epub 2006 Dec 6. 2006
13ZNF423
OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways.
Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A, Massague J.
Cell 100(2):229-40. 2000
14ADGRL2, ADGRL3, ADNP, AKAP9, ANGEL1, ARHGAP32, ATP10B, ATP1A2, BAG5, BAIAP3, CAMKK2, CLCC1, CLSTN3, DDHD2, DDN, DDX46, DDX46, DGKB, DIP, DOCK4, DST, EIF5B, EPM2AIP1, FAM131B, FAM153A, FARP2, FCHSD2, GPR116, HDAC9, IPO13, KBTBD11, KIAA0748, KIAA0753, KIAA0754, KIAA0802, KLHL18, LARP1, LRIG2, MAST2, MTUS2, MYO10, MYO1D, NFASC, NRXN3, NUP155, OSBPL2, PCNX, PHF14, PPP1R13B, RAD54L2, RBM12, RHOBTB1, RHOBTB2, RIMS2, SACS, SASH1, SEC24A, SEC24B, SEC24C, SEC24D, SENP6, SLC4A8, SNRNP200, SNX13, SORBS2, SPATA2, SPON1, SUPT7L, SV2A, SV2B, SYNE1, TBKBP1, TCAF1, TMCC1, TMEM63A, TOMM70A, TSPYL4, UBXN7, ULK1, USP34, VPRBP, VPS39, VPS8, WSCD2, XPO7, ZBED1, ZBED1Y, ZNF294, ZNF423, ZNF432
Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.
Nagase T, Ishikawa K, Suyama M, Kikuno R, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O.
DNA Res 5(5):277-86. 1998